» Articles » PMID: 18395972

A Novel Function of CD82/KAI-1 on E-cadherin-mediated Homophilic Cellular Adhesion of Cancer Cells

Overview
Journal Cancer Lett
Specialty Oncology
Date 2008 Apr 9
PMID 18395972
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we analyzed the effect of the metastasis suppressor CD82/KAI-1, a member of the tetraspanin superfamily, on intercellular adhesion on cancer cells. The newly established invasion assay and the cell aggregation assay revealed that CD82 strengthens E-cadherin-mediated intercellular adhesion. Interestingly, ectopic expression of CD82 stabilized E-cadherin/beta-catenin complex formation. Furthermore, CD82 reduced tyrosine phosphorylation of beta-catenin on HGF stimulation. Taken together, CD82 may stabilize or strengthen E-cadherin-dependent intercellular adhesion by regulating beta-catenin-mediated signal transduction on cancer cells, and consequently, prevent cancer cells from seceding from the primary tumor site.

Citing Articles

Tetraspanins: Novel Molecular Regulators of Gastric Cancer.

Deng Y, Cai S, Shen J, Peng H Front Oncol. 2021; 11:702510.

PMID: 34222025 PMC: 8250138. DOI: 10.3389/fonc.2021.702510.


Role of a metastatic suppressor gene KAI1/CD82 in the diagnosis and prognosis of breast cancer.

Al-Khater K, Almofty S, Ravinayagam V, Alrushaid N, Rehman S Saudi J Biol Sci. 2021; 28(6):3391-3398.

PMID: 34121877 PMC: 8176039. DOI: 10.1016/j.sjbs.2021.03.001.


Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82.

Dodla P, Bhoopalan V, Khoo S, Miranti C, Sridhar S BMC Cancer. 2020; 20(1):1211.

PMID: 33298014 PMC: 7724878. DOI: 10.1186/s12885-020-07675-7.


CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer.

Ma Z, Gao Y, Liu W, Zheng L, Jin B, Duan B Dis Markers. 2020; 2020:8899924.

PMID: 33204367 PMC: 7654213. DOI: 10.1155/2020/8899924.


MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway.

Li J, Xu J, Li L, Ianni A, Kumari P, Liu S Theranostics. 2020; 10(14):6467-6482.

PMID: 32483464 PMC: 7255015. DOI: 10.7150/thno.43865.